| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |